NorthStar Impact Funds
  • Home
  • About
  • Team
  • Impact
  • Our Funds
    • Impact Focus Areas
    • Performance & Reports
    • Our Portfolio Companies
    • Ratings & Platforms
  • Insights
  • Unit Price
  • Contact
  • Invest

  • All
  • Insights
  • Insights Reports
26 Jul 2022

Mayne Pharma Launch NEXTSTELLIS in Australia

NEXTSTELLIS was approved by the Therapeutic Goods Administration in November 2021.
Continue Reading »
26 Jul 2022

De.mem Provides Impact Metric

De.mem treated approximately 550 million litres of water across 15 sites in Australia and Singapore.
Continue Reading »
26 Jul 2022

Takeover Bid for Genex

We are pleased that Skip Capital and Stonepeak Partners recognise the value in Genex.
Continue Reading »
25 Jul 2022

MedAdvisor to Acquire GuildLink

MedAdvisor has announced the purchase of GuildLink from the Pharmacy Guild of Australia. This will add 934 pharmacies.
Continue Reading »
04 Jul 2022

Volpara Signs Contract with the Largest Provider of Outpatient Imaging Services in the US

Volpara is pleased to partner with such a large and well-respected organisation as RadNet.
Continue Reading »
30 Jun 2022

Proteomics Research Could Lead to the World’s First Non-invasive Test for Endometriosis

Proteomics has announced the initial analysis of its endometriosis clinical validation study.
Continue Reading »
26 May 2022

Genex is progressing their wind power project

Substantial investment is required to transition the electricity system to net zero emissions. So this is good news.
Continue Reading »
24 May 2022

Scaling regenerative agriculture in Australia

Good news as this has the potential to create plant-based meat, dairy, baked-goods, noodles, and protein supplements.
Continue Reading »
22 May 2022

Lifestyle Communities Acquire a New Site

Good news for Lifestyle Communities as they have acquired a new site in Leopold on the Bellarine Peninsula.
Continue Reading »
Next Page »

Join our community of positive impact investors today.
Sign up for our newsletter.

NorthStar Impact Funds

Launched in January 2017, the Fund is a registered managed investment scheme managed by North Star Impact Pty Limited (Authorised Representative of Longreach Alternatives Pty Limited AFSL 246 747).

© Copyright 2025 NorthStar Impact Funds
Site by Intervision Design
Invest today
  • About
  • Team
  • Our Funds
  • Impact
  • Our Portfolio Companies
  • Invest
  • Contact
  • Disclaimer
  • Privacy
  • Home
  • About
  • Team
  • Impact
  • Our Funds
    • Impact Focus Areas
    • Performance & Reports
    • Our Portfolio Companies
    • Ratings & Platforms
  • Insights
  • Unit Price
  • Contact
  • Invest